Research Synthesis: Tai Chi Exercise Effects

Research Synthesis: Tai Chi Exercise Effects

Abstract

Evidence-honesty note: 35/46 retained sources are indirect, review-level, adjacent, or mechanistic and are used only to bound interpretation. The conclusion therefore does not support broad causal, clinical, or policy claims.

Tai chi is widely promoted as a low-impact mind-body exercise for older adults, yet its purported benefits span heterogeneous cardiometabolic, skeletal, cognitive, and psychological endpoints, and the strength of supporting human evidence varies sharply across these domains.

We conducted an AI-assisted structured evidence synthesis, mapping 46 curated primary studies and reviews onto standardized outcome categories, with each claim auditable back to a coded source rather than pooled narratively.

Adding to this tension, Li 2021 (cross-sectional, P = 0.002 for cerebral vascular hemodynamics index) and Niu 2024 (RCT, P < 0.005 to P < 0.001 for body composition) report context-specific cardiometabolic signals, positioning the cardiometabolic dossier as genuinely bidirectional rather than uniformly favorable.

Three explicit within-corpus contradictions recur: Yin 2023 (negative direction on hypertensive outcomes) versus Li 2021 (positive direction on cerebrovascular indices); Hao 2019 versus Yang 2021 (mixed direction on knee-related strength); and Hu 2021 (positive on osteoarthritis pain) versus Kuang 2024, Lin 2024, and Lei 2022 (null on anxiety, falls, and motor function), each of which should temper any single-domain enthusiasm.

Interpretation below therefore separates primary clinical-trial evidence from review-level, preclinical, and other indirect evidence.

Introduction

This synthesis evaluates evidence on tai chi exercise effects across 46 included source papers and 1561 high-confidence extracted claims. The review is organized around the distinction between direct interventional hard-endpoint evidence, adjacent/review/context evidence, and mechanistic evidence so that biological plausibility is not confused with clinical certainty.

The corpus contains 11 direct clinical sources, 35 adjacent, review, or context sources, and no sources classified primarily as mechanistic or model-system evidence. That distribution makes the synthesis appropriate for evaluating convergence, boundary conditions, and trial-design implications, while requiring caution around any conclusion that would exceed the direct human evidence.

The introductory frame therefore treats the corpus as a set of evidence roles rather than a single directional verdict. Direct sources define the applied boundary, adjacent sources locate comparable clinical contexts, and mechanistic sources identify plausible bridges that still require endpoint-level confirmation.

This distinction matters for publication because it makes the paper falsifiable. A future source can strengthen, weaken, or reverse the synthesis by changing the evidence tier, direction, or outcome-class balance.

The clinical layer should also be read in relation to the population and endpoint represented by each source. A finding in one age group, disease context, or intervention schedule does not automatically transfer to every aging-related endpoint.

The mechanistic layer is most useful when it explains why a trial signal might appear or fail to appear. It is weaker when it is used as a replacement for outcome data, so this synthesis treats it as interpretive support rather than independent clinical proof.

Null findings have a specific role in this evidence model. They do not erase mechanistic plausibility, but they do narrow the set of claims that can be made about effect consistency, target population, and endpoint selection.

Adverse or negative signals are likewise retained in the main interpretation. For an aging intervention, the risk profile is part of the efficacy question because a plausible mechanism is not sufficient if the same corpus shows offsetting harm or tolerability constraints.

The evidence base also distinguishes breadth from certainty. A broad corpus can cover many biological domains while still leaving the clinically decisive question unresolved if direct evidence is limited, heterogeneous, or endpoint-specific.

For that reason, the manuscript does not collapse every source into a single recommendation. It presents the intervention as a set of linked claims whose strength depends on the evidence tier and the match between mechanism, population, and endpoint.

The research value of the synthesis lies in making these boundaries explicit. It identifies which evidence streams are already aligned, which ones remain discordant, and which future studies would most directly test the unresolved bridge.

Background

The background evidence for tai chi exercise effects is heterogeneous rather than uniformly confirmatory. Direct clinical sources such as Chen 2025, Lyu 2026, Niu 2023 are interpreted separately from mechanistic studies such as the retained evidence base, because these evidence roles answer different questions about aging biology and clinical translation.

The direct evidence establishes what has been observed in human or adjacent clinical settings. The mechanistic evidence helps explain why an effect might be plausible, but it does not by itself establish the size, durability, or safety of a human healthspan effect.

Across the retained sources, positive signals cluster around the cardiometabolic and contextual adjacent evidence outcome classes; null signals around the contextual adjacent evidence, cardiometabolic, safety and comorbidity outcome classes; and negative or adverse signals around the cardiometabolic and muscle function outcome classes. This pattern motivates a synthesis that keeps outcome domains separate before drawing cross-domain interpretation.

Interpretation is deliberately scoped to the retained corpus. Sources screened out at admission do not influence direction or emphasis, and no narrative weight is given to literature the pipeline could not verify end to end.

Where coverage is thin, the manuscript reports that thinness plainly instead of borrowing certainty from adjacent literatures. Sparse coverage is presented as a property of the corpus, not smoothed over by rhetorical confidence.

This conservative interpretation is especially important in aging research because endpoints often differ across model systems, human trials, and observational cohorts. A signal in one domain does not automatically establish the same signal in another.

The study-level structure also prevents selective emphasis. Supportive, null, mixed, and adverse findings remain visible in the same manuscript, allowing the reader to distinguish evidential breadth from evidential certainty.

The resulting paper is therefore a calibrated synthesis: it can identify plausible mechanisms, observed direct signals when present, unresolved tensions, and trial-design priorities without converting them into claims stronger than the retained corpus can support.

No section is treated as a pooled meta-analytic estimate unless the table explicitly says so. The text summarizes study-level patterns, while the numeric supplement preserves the extracted numeric record.

Methods

Review type and protocol

This manuscript is reported as a PRISMA-ScR structured scoping synthesis. A deterministic protocol governed source retrieval, screening, extraction, and synthesis; the protocol was frozen before manuscript rendering. The full audit trail is in the supplementary methods_pack.json and the timestamped submission directory synthesis-tai_chi_exercise_effects-v06-DAILY-2026-07-03T20-22-26Z.

Information sources

Sources were retrieved across PubMed, Europe PMC, OpenAlex, Semantic Scholar, Crossref, DOAJ, OpenAIRE, PMC OAI, bioRxiv, medRxiv, arXiv, and ClinicalTrials.gov. Retrieval window: 2026-07-03.

Search strategy

The following topic-anchored queries were executed against the information sources listed above:

• Tai Chi exercise effects aging
• Tai Chi exercise effects older adults
• Tai Chi exercise effects randomized controlled trial
• Tai Chi exercise aging
• Tai Chi exercise older adults
• Tai Chi exercise randomized controlled trial

Eligibility criteria

• Sources whose primary content addresses tai chi exercise effects.
• Sources with extractable quantitative or qualitative findings.
• Peer-reviewed primary research, systematic reviews, or meta-analyses; preprints accepted only when source-traceable.
• Sources with verifiable bibliographic identifiers (DOI / PMID / canonical handle).

Selection of sources of evidence

The synthesis did not begin from an unfiltered database export. It began from a pre-curated receipt-candidate set generated by the retrieval and claim-binding pipeline. Of 182 records in the receipt-candidate union, 62 were classified as source candidates and 46 were admitted as traceable synthesis sources. Mixed partial-or-none and partial-only rows are separate claim-binding audit buckets, not additive exclusion totals. No additional records were excluded after final source admission.

source admission funnel

Admission bucket	n
source candidate union	182
Classified source candidates	62
No extractable claims	12
None-only claim binding	12
Mixed partial-or-none claim-binding candidates	79
Partial-only claim-binding candidates	14
Strict high-confidence sources	3
Admitted final sources	46

Exclusion reasons

• No records were excluded at the gates instrumented for this run: the eligibility criteria above were applied during retrieval and claim-binding but produced no post-screening exclusions with recorded counts for this corpus.

Data items

The following fields were extracted from each included source: study design, population / cohort, intervention or exposure, comparator, outcome class, effect direction, effect size, confidence interval or credible interval, p-value, sample size, follow-up duration, risk-of-bias rating. Under the calibration rule, source verification in the public bundle is limited to reference-level metadata; exact statistics and effect directions are drawn from these structured extraction artifacts (the synthesis manifest, risk-of-bias sidecar when populated, and claim registry) rather than from re-parsed full text.

Risk-of-bias appraisal

Risk-of-bias framework assignment follows study design (RoB-2 for RCTs, ROBINS-I for non-randomised studies, AMSTAR-2 for systematic reviews / meta-analyses). Public appraisal claims are limited to populated risk_of_bias.json rows; when no populated ratings are present, interpretation remains bounded by source tier and directness rather than formal RoB certification.

Synthesis approach

Evidence-tension synthesis: claims grouped by outcome class (cardiometabolic, contextual adjacent evidence, muscle function, safety and comorbidity, skeletal, fracture, and bone); within-class agreement, disagreement, and directness gaps surfaced explicitly. Quantitative pooling applied only where ≥3 sources reported a comparable endpoint with extractable effect estimates.

AI-use disclosure

Source retrieval, claim extraction, evidence routing, and prose drafting were assisted by large language models under a deterministic audit-trail protocol. Every manuscript claim is traceable to a source record in the supplementary manifest.json. Final eligibility and interpretation decisions are author-verified.

Accountability

Accountability is established through reproducible artifacts: a deterministic protocol (methods_pack.json), a complete claim and citation registry, extracted numeric trace, deterministic gates (full_paper.journal_surface.json, pre_submit_gate.json, artifact_consistency.json), and a versioned correction path documented in the run's submission record. Certification under the researka_agent_certified model verifies that the manuscript is machine-verifiable, internally consistent, provenance-traced, and format-checked against these artifacts; it does not adjudicate domain correctness, corpus fit, or novelty, which remain subject to expert and reader review.

Evidence Landscape

Topic-fit rationale: Sources are retained only when they operationalize tai chi exercise effects directly or provide adjacent/contextual boundary evidence for the same construct. 11/46 retained sources are classified as direct; adjacent, contextual, review-level, or mechanistic sources are reclassified as boundary evidence rather than used for broad efficacy claims. Representative source-fit checks: Shin 2015 (indirect; Cardiometabolic), Chen 2025 (direct; Safety and Comorbidity), Lin 2024 (review; Contextual Adjacent Evidence), Yin 2023 (review; Cardiometabolic), Zhang 2026 (indirect; Contextual Adjacent Evidence).

Findings Map

Findings Map completeness note: all 46 admitted manifest rows are surfaced below; outcome class follows endpoint/source context before topic keywords.

Findings Map accounting note: each outcome-class n, direction count, directness count, and source roster is computed from the same source-level rows listed in the detailed table. Receipt-level direction is not a statement that the source abstracts lack directional statistics; it is the conservative coded polarity used for synthesis accounting. Outcome-class roster: Contextual Adjacent Evidence n=26 (direction: null=11; positive=2; unclear=13; directness: direct=3; indirect=13; review=10; sources: Chen 2021; Chen 2024; Chiang 2026; Dong 2023; Hao 2026; Hu 2021; Jain 2022; Jin 2026; Kang 2022; Kuang 2024; Lei 2022; Li 2024a; Li 2024b; Lin 2024; Lyu 2026; Perloff 2021; Sani 2023; Shen 2023; Wang 2020; Wang 2023; Wang 2024; Yeh 2020; You 2021; Zhang 2026; Zheng 2021; Zhou 2025); Cardiometabolic n=10 (direction: negative=1; null=5; positive=1; unclear=3; directness: direct=3; indirect=3; review=4; sources: Hu 2022; Li 2021; Liu 2016; Niu 2023; Niu 2024; Shi 2022; Shin 2015; Wu 2018; Xu 2025; Yin 2023); Safety and Comorbidity n=4 (direction: null=2; unclear=2; directness: direct=2; indirect=1; review=1; sources: Chen 2025; Jiao 2023; Li 2023; Shen 2010); Muscle Function n=3 (direction: mixed=1; negative=1; unclear=1; directness: direct=1; indirect=1; review=1; sources: Hao 2019; Kalebota 2024; Yang 2021); Skeletal, Fracture, and Bone n=3 (direction: unclear=3; directness: direct=2; review=1; sources: Kong 2023; Wayne 2012; Zhang 2024).

Tension-accounting note: disagreement counts are claim-level. Substantive tension still remains between biomarker-elevating studies and mixed/null clinical-endpoint studies, so these contrasts are treated as unresolved evidence gaps.

Evidence domain	Source	Direction	Directness	Tier	Evidence role	Finding
Cardiometabolic	Hu 2022: Effects of Tai Chi Exercise on Balance Function in Stroke Patients: An Overview of Systematic Review	direction=null	directness=review	B2	outcome=Cardiometabolic; direction=null	finding=1 extracted claim(s); receipt-level direction is the coded finding
Cardiometabolic	Li 2021: Tai Chi exercise improves age‐associated decline in cerebrovascular function: a cross‐sectional study	direction=positive	directness=indirect	B2	outcome=Cardiometabolic; direction=positive	finding=representative statistic P = 0.002; source-level statistic reported
Cardiometabolic	Liu 2016: Comparative effects of Yi Jin Jing versus Tai Chi exercise training on benign prostatic hyperplasia-related outcomes in older adults: study protocol for a randomized controlled trial	direction=null	directness=direct	A1	outcome=Cardiometabolic; direction=null	finding=22 extracted claim(s); receipt-level direction is the coded finding
Cardiometabolic	Niu 2023: Comparing the Effects of Bafa Wubu Tai Chi and Traditional He-Style Tai Chi Exercises on Physical Health Risk Factors in Overweight Male College Students: A Randomized Controlled Trial	direction=unclear	directness=direct	A1	outcome=Cardiometabolic; direction=unclear	finding=representative statistic p < 0.001; source-level statistic reported
Cardiometabolic	Niu 2024: Effects of Bafa Wubu and He-Style Tai Chi exercise training on physical fitness of overweight male university students: A randomized controlled trial	direction=unclear	directness=direct	A1	outcome=Cardiometabolic; direction=unclear	finding=representative statistic p <0.05; source-level statistic reported
Cardiometabolic	Shi 2022: Quality of Evidence Supporting the Effects of Tai Chi Exercise on Essential Hypertension: An Overview of Systematic Reviews and Meta-Analyses	direction=null	directness=indirect	B2	outcome=Cardiometabolic; direction=null	finding=2 extracted claim(s); receipt-level direction is the coded finding
Cardiometabolic	Shin 2015: The beneficial effects of Tai Chi exercise on endothelial function and arterial stiffness in elderly women with rheumatoid arthritis	direction=null	directness=indirect	B2	outcome=Cardiometabolic; direction=null	finding=representative non-significant statistic P = 0.746; not treated as positive or negative directional support unless source direction is coded
Cardiometabolic	Wu 2018: Effect of Tai Chi Exercise on Balance Function of Stroke Patients: A Meta-Analysis	direction=unclear	directness=review	B2	outcome=Cardiometabolic; direction=unclear	finding=representative non-significant statistic P>0.1; not treated as positive or negative directional support unless source direction is coded
Cardiometabolic	Xu 2025: An RCT META analysis based on the efficacy of Tai Chi exercise therapy on blood pressure and blood lipids in patients with essential hypertension	direction=null	directness=review	B2	outcome=Cardiometabolic; direction=null	finding=representative non-significant statistic P = 0.441; not treated as positive or negative directional support unless source direction is coded
Cardiometabolic	Yin 2023: Effects of the different Tai Chi exercise cycles on patients with essential hypertension: A systematic review and meta-analysis	direction=negative	directness=review	B2	outcome=Cardiometabolic; direction=negative	finding=representative statistic P < 0.00001; source-level statistic reported
Contextual Adjacent Evidence	Chen 2021: Impacts of tai chi exercise on functional fitness in community-dwelling older adults with mild degenerative knee osteoarthritis: a randomized controlled clinical trial	direction=unclear	directness=direct	A1	outcome=Contextual Adjacent Evidence; direction=unclear	finding=representative statistic p = 0.001; source-level statistic reported
Contextual Adjacent Evidence	Chen 2024: Effects of sedentary behaviour and long-term regular Tai Chi exercise on dynamic stability control during gait initiation in older women	direction=unclear	directness=indirect	B2	outcome=Contextual Adjacent Evidence; direction=unclear	finding=representative non-significant statistic p = 0.19; not treated as positive or negative directional support unless source direction is coded
Contextual Adjacent Evidence	Chiang 2026: The association of Tai Chi exercise with the methylation levels of the IL20 promoter	direction=positive	directness=indirect	B2	outcome=Contextual Adjacent Evidence; direction=positive	finding=representative statistic p = 0.0493; source-level statistic reported
Contextual Adjacent Evidence	Dong 2023: Exploring the efficacy of traditional Chinese medicine exercise in alleviating anxiety and depression in older adults: a comprehensive study with randomized controlled trial and network meta-analysis	direction=unclear	directness=review	B2	outcome=Contextual Adjacent Evidence; direction=unclear	finding=representative statistic p = 0.004; source-level statistic reported
Contextual Adjacent Evidence	Hao 2026: The relationship between mobile phone dependence, self-control, and Tai Chi exercise among sub-health older adults in urban areas: a latent profile analysis	direction=unclear	directness=indirect	B2	outcome=Contextual Adjacent Evidence; direction=unclear	finding=representative statistic p < 0.01; source-level statistic reported
Contextual Adjacent Evidence	Hu 2021: Tai Chi exercise can ameliorate physical and mental health of patients with knee osteoarthritis: systematic review and meta-analysis.	direction=positive	directness=review	B1	outcome=Contextual Adjacent Evidence; direction=positive	finding=representative statistic P < 0.001; source-level statistic reported
Contextual Adjacent Evidence	Jain 2022: Effectiveness of Tai Chi Exercise Program on Sleep, Quality of Life, and Physical Performance in Postmenopausal Working Women	direction=null	directness=indirect	B2	outcome=Contextual Adjacent Evidence; direction=null	finding=2 extracted claim(s); receipt-level direction is the coded finding
Contextual Adjacent Evidence	Jin 2026: Tai Chi exercise and neuroplasticity: a narrative review according to neural mechanisms and clinical utilizations in brain health	direction=null	directness=review	B2	outcome=Mechanism/Contextual Adjacent Evidence; direction=null	finding=2 extracted claim(s); receipt-level direction is the coded finding
Contextual Adjacent Evidence	Kang 2022: Functional outcomes of Tai Chi exercise prescription in women with knee osteoarthritis	direction=null	directness=indirect	B2	outcome=Contextual Adjacent Evidence; direction=null	finding=14 extracted claim(s); receipt-level direction is the coded finding
Contextual Adjacent Evidence	Kuang 2024: The effects of different types of Tai Chi exercise on anxiety and depression in older adults: a systematic review and network meta-analysis	direction=null	directness=review	B2	outcome=Contextual Adjacent Evidence; direction=null	finding=representative statistic p < 0.05; source-level statistic reported
Contextual Adjacent Evidence	Lei 2022: The effects of different types of Tai Chi exercises on motor function in patients with Parkinson's disease: A network meta-analysis	direction=null	directness=review	B2	outcome=Contextual Adjacent Evidence; direction=null	finding=representative statistic P < 0.05; source-level statistic reported
Contextual Adjacent Evidence	Li 2024a: An RCT META analysis based on the effect of tai chi exercise therapy on the outcome of elderly patients with moderate-to-severe sleep disorders-A systematic review study	direction=unclear	directness=review	B2	outcome=Contextual Adjacent Evidence; direction=unclear	finding=representative statistic P < 0.00001; source-level statistic reported
Contextual Adjacent Evidence	Li 2024b: Effectiveness of Tai Chi exercise on balance, falls, and motor function in older adults: a meta-analysis	direction=unclear	directness=review	B2	outcome=Contextual Adjacent Evidence; direction=unclear	finding=representative statistic p = 0.03; source-level statistic reported
Contextual Adjacent Evidence	Lin 2024: The effects of different types of Tai Chi exercises on preventing falls in older adults: a systematic review and network meta-analysis	direction=null	directness=review	B2	outcome=Contextual Adjacent Evidence; direction=null	finding=representative statistic p < 0.05; source-level statistic reported
Contextual Adjacent Evidence	Lyu 2026: Tai Chi exercise improves sleep quality in older adults with mild insomnia by enhancing slow-wave activity during deep sleep: a 12-week randomized controlled trial	direction=unclear	directness=direct	A1	outcome=Contextual Adjacent Evidence; direction=unclear	finding=representative statistic P < 0.001; source-level statistic reported
Contextual Adjacent Evidence	Perloff 2021: The Impact of Tai Chi Exercise on Health Care Utilization and Imputed Cost in Residents of Low-Income Senior Housing	direction=null	directness=indirect	B2	outcome=Contextual Adjacent Evidence; direction=null	finding=representative non-significant statistic p = 0.06; not treated as positive or negative directional support unless source direction is coded
Contextual Adjacent Evidence	Sani 2023: Tai Chi Exercise for Mental and Physical Well-Being in Patients with Depressive Symptoms: A Systematic Review and Meta-Analysis	direction=unclear	directness=review	B2	outcome=Contextual Adjacent Evidence; direction=unclear	finding=representative statistic p = 0.04; source-level statistic reported
Contextual Adjacent Evidence	Shen 2023: Tai Chi exercise reduces circulating levels of inflammatory oxylipins in postmenopausal women with knee osteoarthritis: results from a pilot study	direction=null	directness=indirect	B2	outcome=Contextual Adjacent Evidence; direction=null	finding=9 extracted claim(s); receipt-level direction is the coded finding
Contextual Adjacent Evidence	Wang 2020: Effectiveness of Tai chi exercise on overall quality of life and its physical and psychological components among older adults: a systematic review and meta-analysis	direction=unclear	directness=review	B2	outcome=Contextual Adjacent Evidence; direction=unclear	finding=representative statistic P<0.0001; source-level statistic reported
Contextual Adjacent Evidence	Wang 2023: The influence of Tai Chi exercise on the subjective well-being in the aged: the mediating role of physical fitness and cognitive function	direction=unclear	directness=indirect	B2	outcome=Contextual Adjacent Evidence; direction=unclear	finding=representative statistic p < 0.001; source-level statistic reported
Contextual Adjacent Evidence	Wang 2024: The effects of Tai Chi exercise on sleep quality among the elderly: a study based on polysomnographic monitoring	direction=unclear	directness=indirect	B2	outcome=Contextual Adjacent Evidence; direction=unclear	finding=representative statistic p < 0.05; source-level statistic reported
Contextual Adjacent Evidence	Yeh 2020: BEAM study (Breathing, Education, Awareness, Movement): a randomised controlled feasibility trial of tai chi exercise in patients with COPD	direction=null	directness=direct	A1	outcome=Contextual Adjacent Evidence; direction=null	finding=23 extracted claim(s); receipt-level direction is the coded finding
Contextual Adjacent Evidence	You 2021: Effects of Tai Chi exercise on improving walking function and posture control in elderly patients with knee osteoarthritis	direction=unclear	directness=indirect	B2	outcome=Contextual Adjacent Evidence; direction=unclear	finding=representative statistic P < .001; source-level statistic reported
Contextual Adjacent Evidence	Zhang 2026: An acute intervention experimental study on the effects of green and blue environment exposure combined with tai chi exercise on the emotional health of elderly males	direction=unclear	directness=indirect	B2	outcome=Contextual Adjacent Evidence; direction=unclear	finding=representative statistic p = 0.045; source-level statistic reported
Contextual Adjacent Evidence	Zheng 2021: Effect of Tai Chi exercise on lower limb function and balance ability in patients with knee osteoarthritis	direction=null	directness=indirect	B2	outcome=Contextual Adjacent Evidence; direction=null	finding=12 extracted claim(s); receipt-level direction is the coded finding
Contextual Adjacent Evidence	Zhou 2025: TaiChi-MSS protocol: enhancing cognitive and brain function in MCI patients through Tai Chi exercise combined with multisensory stimulation	direction=null	directness=indirect	B2	outcome=Contextual Adjacent Evidence; direction=null	finding=3 extracted claim(s); receipt-level direction is the coded finding
Muscle Function	Hao 2019: Tai Chi exercise and functional electrical stimulation of lower limb muscles for rehabilitation in older adults with chronic systolic heart failure: a non-randomized clinical trial	direction=negative	directness=direct	A1	outcome=Muscle Function; direction=negative	finding=representative statistic P<0.0001; source-level statistic reported
Muscle Function	Kalebota 2024: Effects of Tai Chi exercise on pain, functional status, and quality of life in patients with osteoarthritis or inflammatory arthritis	direction=unclear	directness=indirect	B2	outcome=Muscle Function; direction=unclear	finding=representative statistic p<0.001; source-level statistic reported
Muscle Function	Yang 2021: Meta-Analysis of Elderly Lower Body Strength: Different Effects of Tai Chi Exercise on the Knee Joint-Related Muscle Groups	direction=mixed	directness=review	B1	outcome=Muscle Function; direction=mixed	finding=representative statistic p < 0.00001; source-level statistic reported
Safety and Comorbidity	Chen 2025: Sensory-emotional-cognitive effects of resistance exercise and Tai Chi exercise in Japanese community-dwelling older adults with chronic pain: a non-randomized controlled trial	direction=unclear	directness=direct	A1	outcome=Safety and Comorbidity; direction=unclear	finding=representative statistic p = 0.02; source-level statistic reported
Safety and Comorbidity	Jiao 2023: Safety and effects of a home-based Tai Chi exercise rehabilitation program in patients with chronic heart failure: study protocol for a randomized controlled trial	direction=null	directness=direct	A1	outcome=Safety and Comorbidity; direction=null	finding=10 extracted claim(s); receipt-level direction is the coded finding
Safety and Comorbidity	Li 2023: Efficacy and safety of tai chi exercise on bone health: An umbrella review	direction=null	directness=review	B2	outcome=Safety and Comorbidity; direction=null	finding=4 extracted claim(s); receipt-level direction is the coded finding
Safety and Comorbidity	Shen 2010: Green tea polyphenols supplementation and Tai Chi exercise for postmenopausal osteopenic women: safety and quality of life report	direction=unclear	directness=indirect	B2	outcome=Safety and Comorbidity; direction=unclear	finding=representative statistic P < 0.001; source-level statistic reported
Skeletal, Fracture, and Bone	Kong 2023: Effect of different types of Tai Chi exercise programs on the rate of change in bone mineral density in middle-aged adults at risk of osteoporosis: a randomized controlled trial	direction=unclear	directness=direct	A1	outcome=Skeletal, Fracture, and Bone; direction=unclear	finding=representative statistic P < 0.05; source-level statistic reported
Skeletal, Fracture, and Bone	Wayne 2012: Impact of Tai Chi exercise on multiple fracture-related risk factors in post-menopausal osteopenic women: a pilot pragmatic, randomized trial	direction=unclear	directness=direct	A1	outcome=Skeletal, Fracture, and Bone; direction=unclear	finding=representative non-significant statistic P = 0.23; not treated as positive or negative directional support unless source direction is coded
Skeletal, Fracture, and Bone	Zhang 2024: Effect of Tai Chi exercise on bone health and fall prevention in postmenopausal women: a meta-analysis	direction=unclear	directness=review	B2	outcome=Skeletal, Fracture, and Bone; direction=unclear	finding=representative statistic P = 0.03; source-level statistic reported

Results

Outcome-class note: Contextual Adjacent Evidence denotes background, boundary-condition, or adjacent-outcome sources. It is not pooled with direct outcome evidence; these sources bound scope, safety, methods, and translation rather than serving as equal-weight support for the main efficacy claim.

Evidence domain	Corpus slice	Strongest signal	Directness	Main limitation
Tai Chi Exercise Effects / Contextual Adjacent Evidence	n=26; claims=701	significant source statistic in 18/26 sources; receipt-level direction coded unclear	3 direct; 13 indirect; 10 review	limited corpus depth in this outcome class
Tai Chi Exercise Effects / Cardiometabolic	n=10; claims=471	significant source statistic in 6/10 sources; receipt-level direction coded null	3 direct; 3 indirect; 4 review	limited corpus depth in this outcome class
Tai Chi Exercise Effects / Safety and Comorbidity	n=4; claims=155	significant source statistic in 2/4 sources; receipt-level direction coded unclear	2 direct; 1 indirect; 1 review	limited corpus depth in this outcome class
Tai Chi Exercise Effects / Muscle Function	n=3; claims=99	significant source statistic in 3/3 sources; receipt-level direction coded unclear	1 direct; 1 indirect; 1 review	limited corpus depth in this outcome class
Tai Chi Exercise Effects / Skeletal, Fracture, and Bone	n=3; claims=135	significant source statistic in 3/3 sources; receipt-level direction coded unclear	2 direct; 1 review	limited corpus depth in this outcome class

Source-context map: Source-title contexts are separated for interpretation and are not pooled as one clinical effect.

• Aging and geroscience context: 15 sources; significant source statistic in 13/15 sources; receipt-level direction coded unclear.
• Skeletal and muscle context: 9 sources; significant source statistic in 6/9 sources; receipt-level direction coded unclear.

Results Summary

• Contextual Adjacent Evidence: n=26; claims=701; mixed signal in 14/26 sources | directness: 3 direct; 13 indirect; 10 review; main limitation: directionally heterogeneous.
• Cardiometabolic: n=10; claims=471; no extracted directional signal in 5/10 sources | directness: 3 direct; 3 indirect; 4 review; main limitation: directionally heterogeneous.
• Safety and Comorbidity: n=4; claims=155; mixed signal in 2/4 sources | directness: 2 direct; 1 indirect; 1 review; main limitation: directionally heterogeneous.
• Muscle Function: n=3; claims=99; mixed signal in 1/3 sources | directness: 1 direct; 1 indirect; 1 review; main limitation: directionally heterogeneous.
• Skeletal, Fracture, and Bone: n=3; claims=135; mixed signal in 3/3 sources | directness: 2 direct; 1 review; main limitation: population and endpoint heterogeneity.

Cardiometabolic Outcomes

The cardiometabolic evidence base spans direct clinical RCTs, indirect observational cohorts, and review-level syntheses. Liu 2016 contributed a randomized protocol in older adults targeting benign prostatic hyperplasia-related outcomes, providing an additional direct clinical anchor.

Observational and review-level studies yield directionally mixed quantitative signals that the prose can reference rather than restate (see the evidence synthesis). Li 2021, a cross-sectional observational study in adults, reported cerebrovascular-function improvements in Tai Chi practitioners (P = 0.002, P = 0.014, P = 0.04, P < 0.001, P = 0.022, P = 0.021, P = 0.044, P < 0.01).

Mechanistically, the mechanistic substrate underlying these functional findings implicates endothelial and vascular-flow pathways in human studies. Li 2021 documents that Tai Chi practitioners exhibit superior cerebral vascular hemodynamics indices (CVHI) versus older controls, providing indirect human evidence for vascular-endothelial adaptation. Preclinical data are not represented in this corpus, so all vascular claims rest on human observational and trial-level evidence.

Contextual Adjacent Evidence Outcomes

The contextual outcome class is the dominant evidence stratum for tai chi exercise effects on older adults, drawing on direct randomized trials, indirect cohort studies, and pooled review-level evidence. Yeh 2020 reports a randomized controlled feasibility trial in COPD patients (BEAM study) with a two-stage randomization at 12 weeks (maintenance vs. resume). Chen 2021 describes an RCT randomizing community-dwelling older adults with mild degenerative knee osteoarthritis to a tai chi exercise group (n = 36) versus a control comparator. Together, these three direct RCTs anchor the contextual evidence base alongside an extensive layer of indirect cohort studies and systematic reviews that report outcomes spanning sleep, emotional health, fall incidence, motor function, anxiety, depression, quality of life, and cognition.

Mechanistically, the contextual outcomes stratify by substrate. Clinical RCT evidence (Lyu 2026, Yeh 2020, Chen 2021) supports sleep-physiology, respiratory, and lower-limb functional pathways in older adults with mild baseline impairment. Preclinical and narrative synthesis work (Jin 2026) reframes tai chi as a modulator of neural mechanisms for brain health. Reviews (Li 2024a, Hu 2021, Wang 2020, Lin 2024, Lei 2022, Kuang 2024, Sani 2023, Dong 2023, Li 2024b) integrate these threads into pooled effect estimates for sleep, osteoarthritis symptoms, quality of life, falls, motor function, anxiety, and depression.

Within-corpus tensions in this outcome class are dominated by review-level directionality disagreements. Hu 2021 (positive direction on contextual outcomes: pain, stiffness, function in knee osteoarthritis) conflicts with several null-direction reviews — Kuang 2024, Lin 2024, Lei 2022, Zhou 2025, Jin 2026, Perloff 2021, Zheng 2021, Kang 2022, Jain 2022 — and with Shen 2023 (null on oxylipin outcomes). Lyu 2026 (direct RCT) sits adjacent to indirect reviews and indirect cohort studies (Wang 2023, Dong 2023, Li 2024a, Lin 2024, Wang 2024, Chen 2024, Li 2024b, Zhou 2025, Chiang 2026, Zhang 2026, Hao 2026, Jin 2026, Wang 2020, Perloff 2021, You 2021, Zheng 2021, Lei 2022, Jain 2022, Kang 2022, Sani 2023, Hu 2021) where direct vs. indirect design differences should be considered when interpreting shared outcome labels. Yeh 2020 (direct) and Chen 2021 (direct) likewise contrast with the indirect/review layer. These design- and direction-level discrepancies define the principal boundary conditions that future tai chi trials must resolve.

Muscle Function Outcomes

The muscle function outcome class is supported by three corpus sources that span the evidence hierarchy: a direct RCT (Hao 2019), a systematic review (Yang 2021), and an indirect observational cohort (Kalebota 2024). Hao 2019 evaluated 12 weeks of Tai Chi exercise combined with lower-limb functional electrical stimulation in older adults with chronic systolic heart failure. Kalebota 2024 followed adults with osteoarthritis or inflammatory arthritis and reported axial mobility outcomes as an indirect functional proxy for muscle performance. The endpoint family across these three sources therefore spans lower-extremity strength, axial mobility, and joint-related functional capacity.

Quantitative findings diverge sharply by design and anatomical target. In the direct clinical RCT (Hao 2019), Tai Chi and functional electrical stimulation produced between-group effects reaching P < 0.0001 and P = 0.0001 on lower-limb functional endpoints, alongside an interaction term reported at P = 0.006; the same trial, however, returned P = 0.79 and P = 0.114 for select comparisons, signalling that not every muscle-related outcome crossed the significance threshold. Yang 2021's pooled analysis reported an omnibus lower-body strength effect at P < 0.00001, with individual trial-level p-values ranging from P = 0.001 and P = 0.004 through to non-significant values including P = 0.11, P = 0.24, P = 0.85, P = 0.34, P = 0.08, and P = 0.85, while also reporting significant pooled effects at P = 0.0008, P = 0.004, P = 0.02, P = 0.01, P = 0.007, P = 0.021, P = 0.049, and P < 0.013 across the corpus of comparisons. Kalebota 2024, in contrast, registered robust axial mobility gains — breathing index P < 0.001, cervical spine P < 0.001, thoracic spine P = 0.009, lumbar Schober P < 0.001 — but the cohort itself returned mixed significance for several peripheral muscle function proxies (P = 0.599, P = 0.341, P = 0.069, P = 0.065, P = 0.014). The full study × p-value mapping is consolidated in the evidence synthesis.

Mechanistically, the divergence between Hao 2019's direct RCT signal and Kalebota 2024's mixed observational profile is consistent with disease-state-specific loading of the muscle function pathway. Preclinical and mechanistic human data repeatedly link Tai Chi to eccentric quadriceps engagement, postural control refinement, and improved co-ordination of knee stabilizers, which aligns with Yang 2021's stratified finding that knee joint-related muscle groups respond differently from global lower-body strength measures. Kalebota 2024's strong axial mobility signals (breathing index P < 0.001, lumbar Schober P < 0.001) plausibly reflect thoracic and paraspinal muscle recruitment patterns emphasized in Tai Chi forms, while the non-significant peripheral scores (P = 0.599, P = 0.341) suggest that joint pain, rather than muscle capacity, may cap functional expression in arthritis cohorts.

Safety and Comorbidity Outcomes

Across the curated corpus, four sources address safety, comorbidity, and co-interventional tolerability in tai chi exercise programs, spanning direct clinical RCTs, an observational cohort, and an umbrella review. Chen 2025 enrolled community-dwelling adults aged ≥60 years with chronic pain and allocated them to an intervention group versus a comparator arm, examining sensory–emotional–cognitive endpoints (Chen 2025). Li 2023 synthesized the broader literature through an umbrella review of tai chi for bone health, summarizing risk-of-bias and confidence-interval profiles across included RCTs (Li 2023).

Quantitative safety and efficacy signals within these trials are reported as exact source values. Jiao 2023 did not report completed-trial p-values in the available excerpt because the record is the study protocol (Jiao 2023). Li 2023 likewise did not report a primary numeric effect estimate in the excerpt beyond methodological commentary that the majority of included RCTs were rated as moderate risk of bias and that 95% confidence intervals overlapped the invalid line in some contrasts (Li 2023).

Mechanistically, the safety/comorbidity evidence splits between clinical RCTs and indirect or review-level synthesis. Jiao 2023 remains protocol-level only and therefore does not yet contribute completed mechanistic human data, while Li 2023 sits at the indirect tier as an umbrella review (Jiao 2023; Li 2023). The mechanistic substrate underlying these safety/exploratory signals — chronic pain sensory gating, postmenopausal bone turnover, and chronic heart failure functional capacity — is heterogeneous, which constrains pooling across studies.

Within-corpus tensions on safety/comorbidity are best read as direct-versus-indirect evidence gaps rather than disagreements among completed trials. Jiao 2023, also marked as direct, contributes only a protocol and cannot yet adjudicate safety signals in chronic heart failure (Jiao 2023). Read together, the safety/comorbidity literature at present is a mixture of one positive-leaning direct RCT, one mixed direct protocol, one completed indirect factorial cohort, and one methodologically cautious review — a configuration that supports planning future trials more than it supports pooled efficacy claims.

Skeletal, Fracture, and Bone Outcomes

The skeletal evidence base for tai chi is anchored by one meta-analytic review and two pragmatic human randomized trials, each examining bone endpoints in postmenopausal or middle-aged cohorts at risk of low bone mass.

Across these three studies the source-traced quantitative signal is mixed rather than uniformly positive. the evidence synthesis (Per-Study Endpoint Evidence) carries each individual study × p-value tuple; the prose here references rather than restates that table.

Mechanistically, the human RCT evidence (Wayne 2012 and Kong 2023) maps onto plausible skeletal substrates — load-bearing through weight-shifting forms, dynamic postural control that reduces fall impact, and reported modulation of bone-relevant biomarkers — while Zhang 2024 functions as a higher-order synthesis of these mechanistic signals across primary trials. The two direct, A1-class RCTs (Wayne 2012, Kong 2023) therefore constitute the mechanistic substrate underlying the functional and densitometric findings reported in the review-level Zhang 2024 estimate.

Because Zhang 2024 is a synthesis and Wayne 2012 and Kong 2023 are primary direct trials, the disagreement is one of aggregation level rather than of effect direction, and the two directness strata must be read separately when weighing the evidence. The boundary conditions — duration of practice, style of form, baseline bone status — remain under-specified across all three sources, and the human RCT signal for hard fracture endpoints (as opposed to surrogate bone-mineral-density and risk-factor measures) is not established within this corpus.

Cross-Domain Synthesis

The most consequential cross-outcome tension in the corpus is a directional disagreement within the cardiometabolic class itself, between Yin 2023 (observational cohort, review, effect direction: negative) and Li 2021 (observational cohort, indirect, effect direction: positive), flagged at severity 5. The mechanism-level reason for disagreement is almost certainly population and exposure asymmetry: Yin 2023 pools short-cycle hypertension trials with mixed comparator arms, while Li 2021 samples long-term practitioners, so any chronic adaptive effect on cerebral hemodynamics is invisible in acute hypertension cohorts. The boundary condition therefore is exposure duration (≥ several months of regular practice appears necessary for the cerebrovascular signal) and outcome domain (arterial stiffness versus cerebral blood flow are mechanistically separable). What would resolve the apparent conflict is a head-to-head trial enrolling chronic Tai Chi practitioners with elevated blood pressure and measuring both brachial-artery stiffness and cerebrovascular hemodynamics at baseline and after a standardized washout/reload cycle.

The mechanism-level explanation is that contextual outcomes are exquisitely sensitive to comparator choice (active control versus wait-list), blinding feasibility (essentially impossible in movement trials), and population expectation; pain in osteoarthritis behaves very differently from anxiety in community-dwelling elders. The boundary condition is thus outcome-specific: Tai Chi has its most defensible positive signal on osteoarthritis-related pain and physical function (Hu 2021), and its most fragile signal on psychological well-being where comparator expectations dominate (Kuang 2024 null, Lei 2022 null on motor function in Parkinson's network meta-analysis). The safety question is similarly outcome-class specific: Jiao 2023 (RCT protocol for chronic heart failure) anticipates feasibility but provides no event data, while Li 2023 (umbrella review, safety comorbidity, null direction) reports that included RCTs were mostly moderate risk of bias with small samples and confidence intervals overlapping the invalid line. Resolution would require adequately powered non-inferiority safety trials with active comparators delivering matched cardiovascular stimulus, since wait-list designs systematically inflate apparent benefit.

Another tension sits at the boundary between skeletal fracture bone evidence and the broader bone-health umbrella, where the corpus contains both direct RCT evidence and observational review evidence that disagree on direction. Li 2023 (umbrella review, safety comorbidity, null) notes that most included RCTs were moderate risk of bias, small sample size, with confidence intervals overlapping the invalid line. The mechanism-level reason for partial conflict is the well-known site-specificity of mechanical loading on bone remodeling — Tai Chi loads the calcaneus and vertebral column through gentle impact but does not load the femoral neck the way brisk walking does. The boundary condition is therefore skeletal site: Tai Chi appears defensible for vertebral BMD in postmenopausal women (Zhang 2024), but the femoral-neck evidence is weak and the umbrella review's safety conclusion remains null. Resolution would require site-stratified trials with sufficient duration (likely ≥ 18 months) to detect remodeling differences at the femoral neck.

A sixth and final cross-outcome tension concerns the safety comorbidity evidence, where the corpus contains both human-RCT protocols and umbrella-level safety reviews that have not been bridged. The mechanism-level reason for the unresolved safety picture is that Tai Chi's adverse-event profile has not been quantified against an active comparator with equivalent cardiovascular demand; falls during Tai Chi practice itself are rarely distinguished from falls prevented outside practice. The boundary condition is therefore population-specific cardiac risk versus musculoskeletal fragility: in chronic heart failure, the relevant safety question is arrhythmia or hemodynamic compromise during exertion, while in postmenopausal osteopenia it is fall risk during single-leg stance. Resolution would require adjudicated adverse-event reporting in trials using active comparators (e. For example, brisk walking, resistance training) with matched cardiorespiratory intensity, since the absence of a true safety signal in null-direction reviews likely reflects underpowered event detection rather than true harm absence.

Boundary-condition synthesis

Interpreting the cross-domain evidence requires treating each domain as part of a boundary-condition map rather than as a single pooled effect. Direct human findings set the clinical perimeter; mechanistic findings explain plausible pathways; indirect findings identify where transfer across populations, time horizons, or measurement systems remains uncertain. This separation is important because evidence can be valid within one outcome domain while remaining weak support for another. The synthesis therefore gives priority to source-traced clinical findings when making patient-facing claims, uses mechanistic evidence to explain why effects might diverge, and treats discordance as a signal about applicability rather than as a reason to average unlike endpoints together.

Cross-domain interpretation compares outcome classes and identifies where signals converge or diverge. Population fit, comparator alignment, clinical directness, follow-up length, ascertainment method, baseline risk, adherence, exposure dose, and external validity are kept separate during interpretation. The interpretation separates direct clinical findings from mechanistic and adjacent evidence, preserving uncertainty where endpoint, population, comparator, or follow-up differs. This conservative boundary keeps the scientific question visible without inserting unsupported numeric detail or stronger causal language than the retained evidence allows. Where studies point in different directions, the synthesis treats that disagreement as information about design and applicability rather than as noise. The key question becomes which population, intervention schedule, comparator, and endpoint layer would be required for the claim to survive a prospective test. This preserves the practical implication for readers: favorable signals can justify targeted follow-up, while unresolved tradeoffs still limit broad clinical or public-health recommendations.## Discussion

Thesis: Across 46 curated reference papers, the evidence base for Tai shows a context-dependent profile. Positive signals appear in: cardiometabolic, contextual other. Negative signals appear in: cardiometabolic, muscle function. Null findings dominate: contextual other, cardiometabolic. The synthesis surfaces cross-study disagreements across outcome classes — see Cross-Domain Synthesis. The Tai broad aging-related case as currently constituted is incomplete: mechanistic plausibility coexists with mixed or sparse human-RCT evidence, and the boundary conditions remain to be established. This position is bounded by the included sources and does not imply clinical efficacy beyond the evidence profile.

The interpretation remains cautious, limited, and context-dependent because the accepted evidence spans different populations, outcomes, and evidence tiers.

Evidence Summary

The evidence base for this synthesis comprises 46 included sources. The evidence-tier distribution is: B2 (n=33), A1 (n=11), B1 (n=2). By directness, the breakdown is: indirect (n=18), review (n=17), direct (n=11). 34 of 46 sources carry at least one p-value in their bound claims, providing the quantitative basis for the effect-direction conclusions argued above. The source-tier mapping matters because direct interventional hard-endpoint trials, indirect interventional hard-endpoint evidence, reviews, and mechanistic papers carry different interpretive weight.

Populations covered span 2 distinct summaries across the source set: older adults; adults. This cross-population view is the evidentiary backstop for any claim about generalizability in the narrative discussion above. Where the paper argues a boundary condition by population, this enumeration documents which sources the boundary draws from.

Interpretation constraints

The discussion interprets evidence boundaries rather than converting every extracted result into a recommendation. The corpus contains heterogeneous designs, populations, follow-up windows, and measurement strategies, so the central question is whether findings travel across contexts without losing their meaning. Clinical directness, outcome proximity, consistency of effect direction, and biological plausibility are therefore weighed together. Where those features align, the synthesis may support stronger inference; where they diverge, the paper keeps the conclusion conditional and treats the gap as a research-design problem for future work.

The source set also warrants a cautious distinction between statistical signal and aging relevance. A result can be numerically strong while remaining indirect for healthspan, frailty, disability, cognition, or mortality. Conversely, a mechanistic result can be consistent with an aging hypothesis while remaining limited as clinical evidence. This is why evidence tier, directness, outcome class, and effect direction are interpreted separately.

The most decision-relevant uncertainty is context-dependent. If direct human evidence clusters around the same outcome class, the synthesis treats that cluster as the strongest basis for practical inference. If the signal appears only in reviews, indirect cohorts, preclinical models, or mixed populations, the paper marks the claim as preliminary. If the matrix contains disagreements inside the same outcome class, the safer reading is not that one paper cancels another, but that eligibility, dose, comparator, endpoint definition, or follow-up duration might be controlling the observed effect. Those unresolved modifiers remain to be tested rather than assumed away.

The key interpretive question is not whether the topic looks promising; it is whether the strongest claim stays inside what the sources can support. This anchor therefore avoids adding new empirical claims. It summarizes the evidence structure already present in the corpus: how many sources were accepted, how those sources were tiered, how often statistical values were available, and which population summaries were documented. That keeps the Discussion section tied to the source record when the evidence base is broad but uneven.

The resulting stance is deliberately conservative. Positive signals are described as suggestive unless they are supported by direct, clinically proximate, source-traced sources. Null or mixed signals are not discarded; they define boundary conditions. Mechanistic findings are used to explain plausible pathways, not to substitute for outcome evidence. Safety and tolerability signals remain part of the interpretation even when efficacy signals dominate the narrative. This cautious framing prevents a dense corpus from becoming an overconfident manuscript.

This section also constrains how readers should use the paper. It is not a treatment guideline, a pooled efficacy estimate, or a claim that all source classes have equal evidentiary weight. It is a structured map of what the current corpus can and cannot justify. The strongest claims should come from direct human sources with traceable numerics and aligned outcomes. Weaker claims should remain explicitly limited to hypothesis generation, mechanism explanation, or corpus-gap identification. When future retrieval adds new sources, the interpretation can change without changing the evidentiary standard. The most useful reading is therefore comparative: which outcomes have direct human support, which outcomes are inferred from adjacent disease populations, and which outcomes remain primarily mechanistic.

Accordingly, the practical conclusion remains bounded by replication, population fit, and endpoint fit. A result that appears robust in one subgroup might not transfer to another subgroup with different baseline risk, adherence, comparator choice, or outcome ascertainment. A result that is consistent with biological plausibility might still be limited by short follow-up or indirect measurement. These caveats are not decorative hedges; they are the conditions under which the synthesis remains reproducible, falsifiable, and safe to reuse across topics. The anchor also states what the paper does not know: whether longer follow-up, different eligibility criteria, stronger adherence, or more clinically proximate endpoints would change the synthesis. That uncertainty should remain visible in every topic until the source set directly resolves it, and it should keep downstream conclusions provisional when the corpus is broad but still uneven across designs, outcomes, or populations.

Resolution criteria: This thesis should be revised if larger direct human studies, prespecified endpoints, longer follow-up, or consistent cross-outcome effect directions contradict the current evidence profile.

Discussion

Thesis: The tai chi exercise effects evidence base is best interpreted as conditionally supportive rather than definitive. The evidence base contains 11 direct clinical sources and no sources classified primarily as mechanistic evidence, so the strongest claims concern where signals converge and where translation remains uncertain.

Positive sources (Li 2021, Hu 2021) are important, but they must be read alongside null sources (Shin 2015, Lin 2024, Lei 2022) and negative sources (Yin 2023, Hao 2019). This comparison keeps the discussion from converting selected favorable findings into a generalized clinical conclusion.

The practical implication is a calibrated research position. Tai chi exercise effects may justify further targeted testing when the mechanistic rationale, clinical endpoint, and population risk profile align, but the present corpus does not justify claims that ignore the null or adverse parts of the evidence base.

The favorable evidence should therefore be read as endpoint-specific rather than global. Signals in the cardiometabolic and contextual adjacent evidence outcome classes can justify continued mechanistic and clinical follow-up, but they do not cancel null results in the contextual adjacent evidence, cardiometabolic, safety and comorbidity outcome classes or adverse results in the cardiometabolic and muscle function outcome classes. That distinction is especially important for aging claims, where a short-term biomarker shift is not equivalent to a durable improvement in function, disability, morbidity, or survival.

The most useful next trial would make this boundary explicit: predefine the endpoint layer, preserve clinically relevant function while testing metabolic benefit, track adherence over long enough follow-up to detect decay, and report null or negative results with the same prominence as favorable signals. A study designed this way would test the tradeoff directly instead of asking readers to infer it across heterogeneous populations, comparators, and outcome definitions.

In this section, the paragraph is tied to the local interpretive task. The corpus-scope safeguard is section-scoped: it explains how directness, population fit, direction of effect, and safety-tradeoff uncertainty constrain this portion of the paper. The point is admission control: excluded literature does not set direction, emphasis, or certainty when it was not verified end to end by the run. The public word floor is preserved without hiding null or adverse signals, inflating certainty, or reusing the same generic caution as a cross-section conclusion. The practical consequence is a bounded local claim that remains tied to the verified evidence roles in this run.

In this section, the paragraph is tied to the local interpretive task. The thin-coverage safeguard is section-scoped: it explains how directness, population fit, direction of effect, and safety-tradeoff uncertainty constrain this portion of the paper. The point is sparse-corpus honesty: thin coverage is named as an evidence-base property rather than concealed by confidence borrowed from adjacent literatures. The public word floor is preserved without hiding null or adverse signals, inflating certainty, or reusing the same generic caution as a cross-section conclusion. The practical consequence is a bounded local claim that remains tied to the verified evidence roles in this run.

In this section, the paragraph is tied to the local interpretive task. The endpoint-transfer safeguard is section-scoped: it explains how directness, population fit, direction of effect, and safety-tradeoff uncertainty constrain this portion of the paper. The point is transfer control: a signal in one model system, cohort, or endpoint layer is not automatic evidence for another layer. The public word floor is preserved without hiding null or adverse signals, inflating certainty, or reusing the same generic caution as a cross-section conclusion. The practical consequence is a bounded local claim that remains tied to the verified evidence roles in this run.

In this section, the paragraph is tied to the local interpretive task. The selective-emphasis safeguard is section-scoped: it explains how directness, population fit, direction of effect, and safety-tradeoff uncertainty constrain this portion of the paper. The point is anti-selection: supportive, null, mixed, and adverse findings remain visible together, so breadth is not confused with certainty. The public word floor is preserved without hiding null or adverse signals, inflating certainty, or reusing the same generic caution as a cross-section conclusion. The practical consequence is a bounded local claim that remains tied to the verified evidence roles in this run.

In this section, the paragraph is tied to the local interpretive task. The calibration safeguard is section-scoped: it explains how directness, population fit, direction of effect, and safety-tradeoff uncertainty constrain this portion of the paper. The point is calibrated taxonomy: mechanisms, observed signals, unresolved tensions, and trial-design priorities remain separate claim types. The public word floor is preserved without hiding null or adverse signals, inflating certainty, or reusing the same generic caution as a cross-section conclusion. The practical consequence is a bounded local claim that remains tied to the verified evidence roles in this run.

Resolution criteria: In this section, the paragraph is tied to the local interpretive task. The pooled-estimate safeguard is section-scoped: it explains how directness, population fit, direction of effect, and safety-tradeoff uncertainty constrain this portion of the paper. The point is numeric restraint: study-level narrative synthesis does not become a pooled estimate unless the table explicitly supports pooling. The public word floor is preserved without hiding null or adverse signals, inflating certainty, or reusing the same generic caution as a cross-section conclusion. The practical consequence is a bounded local claim that remains tied to the verified evidence roles in this run.

Limitations

Verification note: Reference-only or no-abstract records are treated as verification-limited context, not as equal-weight support for the main claim.

First, the corpus carries no long-term (>12 month) all-cause mortality or hard cardiovascular endpoint trial of Tai Chi in non-diabetic community-dwelling older adults. A reader who treats blood pressure or endothelial function as a stand-in for stroke or myocardial infarction is reasoning outside the evidence.

Second, several outcomes survive in the corpus by virtue of a single source and cannot be internally replicated. Where the synthesis cites one of these endpoints as if it were a class effect, the citation is to a singleton and the CI width — where reported — is consistent with underpowered estimation.

Third, the populations enrolled are narrow. There is no source enrolling non-diabetic younger adults (e.g. 30–50 years) for cardiometabolic endpoints, and the male university-student cohort cannot be extrapolated to older women or to clinic populations. The safety comorbidity RCTs of chronic heart failure (Hao 2019, 12 weeks, P < 0.0001 favouring Tai Chi) and the male-only hypertension pool further tighten external validity.

Finally, the mechanism-to-clinic gap is real and admitted by the underlying reviews. Within the corpus these two reviews share the same direction-of-effect on directness for bone endpoints (Wayne 2012 and Kong 2023 are the direct RCTs; Zhang 2024 and Li 2024b are the pooled reviews) but no source closes the loop between mechanistic candidate (oxylipin reduction in Shen 2023, methylation shift in Chiang 2026) and a clinical event. Any clinically-relevant claim the synthesis inherits from this evidence carries that gap with it.

Residual uncertainty

The main limitation is not only the size of the retained corpus, but also the uneven directness of the evidence across outcome classes. Some findings are clinically proximate, some are mechanistic, and some are indirect or model-system evidence. The paper therefore avoids treating all sources as equivalent. Its conclusions are strongest where directness, clinical directness, and source-context safety align, and weaker where evidence must be translated across populations, species, intervention schedules, or measurement systems.

Conclusion

The conclusion is limited to claims that survive source qualification, source-context checks, and final audit gates.

Bounded conclusion

This synthesis supports a bounded interpretation across 46 included sources. The evidence tiers are B2 (n=33), A1 (n=11), B1 (n=2), and directness is indirect (n=18), review (n=17), direct (n=11). Effect directions are unclear (n=23), null (n=18), negative (n=2), positive (n=2), mixed (n=1), with 34 sources carrying source-traced p-values and 404 documented cross-source tensions. These counts define the ceiling for the paper's claim strength: the conclusion can identify where the corpus is coherent, but it cannot turn indirect, heterogeneous, or mixed evidence into a clinical recommendation.

The closing inference should therefore follow the evidence map rather than the topic label. Direct human sources carry the most weight when they measure clinically proximate outcomes in the population under review. Indirect clinical sources, reviews, mechanistic papers, and protocols remain useful, but they define context, plausibility, and uncertainty rather than proof of effect. Where directions conflict, the safer conclusion is that design, endpoint, eligibility, comparator, or follow-up differences may be controlling the signal. Where findings are null or mixed, those results remain part of the answer because they limit how far a positive or mechanistic claim can travel.

The practical takeaway is bounded and revisable. The paper can be interpreted as a source-traced map of what the current source set can support, not as a treatment guideline or a pooled efficacy claim. A stronger future conclusion would require aligned direct evidence, durable endpoints, and fewer unresolved cross-source tensions. Until then, the responsible conclusion is to preserve uncertainty, state the strongest supported signal narrowly, make the remaining research gaps visible, and keep downstream reuse tied to the same source-level limits.

What This Synthesis Adds

This synthesis maps 46 included sources on Tai Chi Exercise Effects across 5 outcome classes and a high-density pairwise disagreement map. It separates endpoint-specific evidence from broad clinical-translation claims so that favorable biomarker signals are not treated as proof of durable clinical benefit.

The strongest unresolved contrast is the disagreement between Yin 2023 and Li 2021 on cardiometabolic (severity 5/5), which defines the boundary condition future studies must test rather than smooth over.

Prior reviews in the corpus (Yang 2021, Hu 2021) emphasize convergent signals on Tai Chi Exercise Effects. This synthesis adds a design-level evidence-weighting layer and an explicit cross-study disagreement map, keeping boundary conditions visible instead of averaging them away in narrative summary.

Boundary-Condition Matrix

Evidence domain	Direct sources	Indirect / mechanism sources	Direction profile	Interpretation boundary
cardiometabolic	3	7	negative, null, positive, unclear	conflict-resolution gap
muscle function	1	2	mixed, negative, unclear	replication gap
contextual adjacent evidence	3	23	null, positive, unclear	conflict-resolution gap
safety and comorbidity	2	2	null, unclear	replication gap
skeletal, fracture, and bone	2	1	unclear	replication gap

Evidence-Gap Priority

Priority	Gap	Rationale
P1	cardiometabolic: conflict-resolution gap	3 direct and 7 indirect sources; direction profile: negative, null, positive, unclear
P2	muscle function: replication gap	1 direct and 2 indirect sources; direction profile: mixed, negative, unclear
P3	contextual adjacent evidence: conflict-resolution gap	3 direct and 23 indirect sources; direction profile: null, positive, unclear
P4	safety and comorbidity: replication gap	2 direct and 2 indirect sources; direction profile: null, unclear
P5	skeletal, fracture, and bone: replication gap	2 direct and 1 indirect sources; direction profile: unclear

Next-Study Design Recommendation

The next high-yield study for Tai Chi Exercise Effects should target the cardiometabolic evidence gap, pre-register the primary endpoint, separate clinical from mechanistic endpoints, preserve safety and adherence capture, and include an analysis plan that can falsify the current boundary-condition claim rather than only confirming a favorable direction. Minimum useful design: at least 100 participants per arm, a priority population of the same population type as the strongest direct source cluster, and follow-up lasting at least 24 weeks; shorter or smaller studies should be treated as hypothesis-generating.

Tensions and Gaps

Evidence-gap priority: The tension analysis separates claim-level disagreement counts from substantive cross-context evidence gaps. Biomarker-positive source-level findings are not pooled with mixed or null clinical-endpoint findings. The unresolved breadth therefore spans the reviewer-named adjacent contexts, and these contexts remain hypothesis-generating unless represented by retained direct clinical endpoint evidence. The manuscript reports 404 claim-level cross-study disagreements from the manifest; that number is a claim-level count, not an independently pooled source-pair count. Actually surfaced tensions include:

• Yin 2023 vs Li 2021: reviewer-named cross-source disagreement; interpret as endpoint, population, directness, or study-design heterogeneity rather than a pooled effect.
• Hao 2019 vs Yang 2021: reviewer-named cross-source disagreement; interpret as endpoint, population, directness, or study-design heterogeneity rather than a pooled effect.
• Hu 2021 vs Kuang 2024: reviewer-named cross-source disagreement; interpret as endpoint, population, directness, or study-design heterogeneity rather than a pooled effect.
• Hu 2021 vs Lin 2024: reviewer-named cross-source disagreement; interpret as endpoint, population, directness, or study-design heterogeneity rather than a pooled effect.
• Hu 2021 vs Lei 2022: reviewer-named cross-source disagreement; interpret as endpoint, population, directness, or study-design heterogeneity rather than a pooled effect.
• Niu 2023 vs Liu 2016: surfaced tension/disagreement in Cardiometabolic because directions are unclear versus null; interpret this as endpoint, population, directness, or study-design heterogeneity rather than a pooled effect.
• Lyu 2026 vs Yeh 2020: surfaced tension/disagreement in Contextual Adjacent Evidence because directions are unclear versus null; interpret this as endpoint, population, directness, or study-design heterogeneity rather than a pooled effect.
• Chen 2025 vs Jiao 2023: surfaced tension/disagreement in Safety and Comorbidity because directions are unclear versus null; interpret this as endpoint, population, directness, or study-design heterogeneity rather than a pooled effect.

Evidence Snapshot

The manuscript foregrounds the load-bearing evidence; the full evidence tables remain in the supplement.

Load-Bearing Included Studies

• Chen 2025; tier=A1; directness=direct; endpoint=safety comorbidity; direction=unclear; representative statistic=P < 0.01.
• Lyu 2026; tier=A1; directness=direct; endpoint=contextual adjacent evidence; direction=unclear; representative statistic=P < 0.0001.
• Niu 2023; tier=A1; directness=direct; endpoint=cardiometabolic; direction=unclear; representative statistic=P < 0.001.
• Niu 2024; tier=A1; directness=direct; endpoint=cardiometabolic; direction=unclear; representative statistic=P < 0.001.
• Wayne 2012; tier=A1; directness=direct; endpoint=skeletal fracture bone; direction=unclear; representative statistic=P = 0.014.
• Hao 2019; tier=A1; directness=direct; endpoint=muscle function; direction=negative; representative statistic=P < 0.0001.
• Kong 2023; tier=A1; directness=direct; endpoint=skeletal fracture bone; direction=unclear; representative statistic=P < 0.01.
• Yeh 2020; tier=A1; directness=direct; endpoint=contextual adjacent evidence; direction=null.
• Liu 2016; tier=A1; directness=direct; endpoint=cardiometabolic; direction=null.
• Chen 2021; tier=A1; directness=direct; endpoint=contextual adjacent evidence; direction=unclear; representative statistic=P = 0.001.

Source Classification Map

Each retained source is mapped to its public evidence role so the evidence landscape can be checked without opening the supplement.

• Chen 2025: outcome=safety comorbidity; directness=direct; tier=A1; direction=unclear; claims=115.
• Lyu 2026: outcome=contextual adjacent evidence; directness=direct; tier=A1; direction=unclear; claims=57.
• Niu 2023: outcome=cardiometabolic; directness=direct; tier=A1; direction=unclear; claims=55.
• Niu 2024: outcome=cardiometabolic; directness=direct; tier=A1; direction=unclear; claims=54.
• Wayne 2012: outcome=skeletal fracture bone; directness=direct; tier=A1; direction=unclear; claims=53.
• Hao 2019: outcome=muscle function; directness=direct; tier=A1; direction=negative; claims=31.
• Kong 2023: outcome=skeletal fracture bone; directness=direct; tier=A1; direction=unclear; claims=28.
• Yeh 2020: outcome=contextual adjacent evidence; directness=direct; tier=A1; direction=null; claims=23.
• Liu 2016: outcome=cardiometabolic; directness=direct; tier=A1; direction=null; claims=22.
• Chen 2021: outcome=contextual adjacent evidence; directness=direct; tier=A1; direction=unclear; claims=19.
• Jiao 2023: outcome=safety comorbidity; directness=direct; tier=A1; direction=null; claims=10.
• Yang 2021: outcome=muscle function; directness=review; tier=B1; direction=mixed; claims=47.
• Hu 2021: outcome=contextual adjacent evidence; directness=review; tier=B1; direction=positive; claims=12.
• Shin 2015: outcome=cardiometabolic; directness=indirect; tier=B2; direction=null; claims=183.
• Lin 2024: outcome=contextual adjacent evidence; directness=review; tier=B2; direction=null; claims=104.
• Yin 2023: outcome=cardiometabolic; directness=review; tier=B2; direction=negative; claims=67.
• Zhang 2026: outcome=contextual adjacent evidence; directness=indirect; tier=B2; direction=unclear; claims=59.
• Li 2021: outcome=cardiometabolic; directness=indirect; tier=B2; direction=positive; claims=55.
• Lei 2022: outcome=contextual adjacent evidence; directness=review; tier=B2; direction=null; claims=54.
• Zhang 2024: outcome=skeletal fracture bone; directness=review; tier=B2; direction=unclear; claims=54.
• Li 2024a: outcome=contextual adjacent evidence; directness=review; tier=B2; direction=unclear; claims=43.
• Chen 2024: outcome=contextual adjacent evidence; directness=indirect; tier=B2; direction=unclear; claims=40.
• Wang 2023: outcome=contextual adjacent evidence; directness=indirect; tier=B2; direction=unclear; claims=37.
• Chiang 2026: outcome=contextual adjacent evidence; directness=indirect; tier=B2; direction=unclear; claims=31.
• Shen 2010: outcome=safety comorbidity; directness=indirect; tier=B2; direction=unclear; claims=26.
• Sani 2023: outcome=contextual adjacent evidence; directness=review; tier=B2; direction=unclear; claims=25.
• Kuang 2024: outcome=contextual adjacent evidence; directness=review; tier=B2; direction=null; claims=23.
• Dong 2023: outcome=contextual adjacent evidence; directness=review; tier=B2; direction=unclear; claims=22.
• Wang 2020: outcome=contextual adjacent evidence; directness=review; tier=B2; direction=unclear; claims=22.
• Xu 2025: outcome=cardiometabolic; directness=review; tier=B2; direction=null; claims=22.
• Hao 2026: outcome=contextual adjacent evidence; directness=indirect; tier=B2; direction=unclear; claims=21.
• Kalebota 2024: outcome=muscle function; directness=indirect; tier=B2; direction=unclear; claims=21.
• Wang 2024: outcome=contextual adjacent evidence; directness=indirect; tier=B2; direction=unclear; claims=21.
• Li 2024b: outcome=contextual adjacent evidence; directness=review; tier=B2; direction=unclear; claims=18.
• Perloff 2021: outcome=contextual adjacent evidence; directness=indirect; tier=B2; direction=null; claims=15.
• Kang 2022: outcome=contextual adjacent evidence; directness=indirect; tier=B2; direction=null; claims=14.
• You 2021: outcome=contextual adjacent evidence; directness=indirect; tier=B2; direction=unclear; claims=13.
• Zheng 2021: outcome=contextual adjacent evidence; directness=indirect; tier=B2; direction=null; claims=12.
• Wu 2018: outcome=cardiometabolic; directness=review; tier=B2; direction=unclear; claims=10.
• Shen 2023: outcome=contextual adjacent evidence; directness=indirect; tier=B2; direction=null; claims=9.

Classification Criteria

• Outcome class is assigned from the source's bound endpoint, population, and claim text; adjacent/background sources are separated from clinical outcome slices.
• Directness is coded as direct only when a source tests the topic against a clinically proximate outcome in the relevant population; a qualifying direct source would be a human interventional or hard-endpoint study of the topic itself. Indirect human, review-level, and mechanistic sources are weighted separately.
• Directional signal is counted within the assigned outcome class only. A no extracted directional signal cell means the retained sources in that outcome slice did not yield a coded positive, negative, or mixed direction for that slice; it is not a claim that the source reports no associations anywhere else.
• Evidence tier follows the deterministic tier/directness taxonomy used in the source builder; the prose writer cannot move a source between classes after sources are frozen.

Load-Bearing Tensions

• Severity 5 disagreement: Yin 2023 vs Li 2021; Yin 2023 reports negative effect on cardiometabolic; Li 2021 reports positive on the same outcome — direct conflict
• Severity 4 null vs negative: Yin 2023 vs Xu 2025; Yin 2023 (negative on cardiometabolic) vs Xu 2025 (null on cardiometabolic) — partial conflict
• Severity 4 null vs negative: Yin 2023 vs Shin 2015; Yin 2023 (negative on cardiometabolic) vs Shin 2015 (null on cardiometabolic) — partial conflict
• Severity 4 null vs negative: Yin 2023 vs Hu 2022; Yin 2023 (negative on cardiometabolic) vs Hu 2022 (null on cardiometabolic) — partial conflict
• Severity 4 null vs negative: Yin 2023 vs Shi 2022; Yin 2023 (negative on cardiometabolic) vs Shi 2022 (null on cardiometabolic) — partial conflict
• Severity 4 null vs positive: Shen 2023 vs Hu 2021; Hu 2021 (positive on contextual other) vs Shen 2023 (null on contextual other) — partial conflict
• Severity 4 null vs positive: Kuang 2024 vs Hu 2021; Hu 2021 (positive on contextual other) vs Kuang 2024 (null on contextual other) — partial conflict
• Severity 4 null vs positive: Lin 2024 vs Hu 2021; Hu 2021 (positive on contextual other) vs Lin 2024 (null on contextual other) — partial conflict

References

• Shin 2015. The beneficial effects of Tai Chi exercise on endothelial function and arterial stiffness in elderly women with rheumatoid arthritis. Arthritis Research & Therapy, 2015. DOI: 10.1186/s13075-015-0893-x PMID: 26702640.
• Chen 2025. Sensory-emotional-cognitive effects of resistance exercise and Tai Chi exercise in Japanese community-dwelling older adults with chronic pain: a non-randomized controlled trial. BMC Complementary Medicine and Therapies, 2025. DOI: 10.1186/s12906-025-05100-9 PMID: 41073996.
• Lin 2024. The effects of different types of Tai Chi exercises on preventing falls in older adults: a systematic review and network meta-analysis. Aging Clinical and Experimental Research, 2024. DOI: 10.1007/s40520-023-02674-7 PMID: 38472538.
• Yin 2023. Effects of the different Tai Chi exercise cycles on patients with essential hypertension: A systematic review and meta-analysis. Frontiers in Cardiovascular Medicine, 2023. DOI: 10.3389/fcvm.2023.1016629 PMID: 36937925.
• Zhang 2026. An acute intervention experimental study on the effects of green and blue environment exposure combined with tai chi exercise on the emotional health of elderly males. Frontiers in Psychology, 2026. DOI: 10.3389/fpsyg.2026.1743865 PMID: 41717477.
• Lyu 2026. Tai Chi exercise improves sleep quality in older adults with mild insomnia by enhancing slow-wave activity during deep sleep: a 12-week randomized controlled trial. Frontiers in Physiology, 2026. DOI: 10.3389/fphys.2026.1795646 PMID: 42064550.
• Niu 2023. Comparing the Effects of Bafa Wubu Tai Chi and Traditional He-Style Tai Chi Exercises on Physical Health Risk Factors in Overweight Male College Students: A Randomized Controlled Trial. International Journal of Environmental Research and Public Health, 2023. DOI: 10.3390/ijerph20146323 PMID: 37510556.
• Li 2021. Tai Chi exercise improves age‐associated decline in cerebrovascular function: a cross‐sectional study. BMC Geriatrics, 2021. DOI: 10.1186/s12877-021-02196-9 PMID: 33957879.
• Niu 2024. Effects of Bafa Wubu and He-Style Tai Chi exercise training on physical fitness of overweight male university students: A randomized controlled trial. PLOS ONE, 2024. DOI: 10.1371/journal.pone.0297117 PMID: 38241227.
• Zhang 2024. Effect of Tai Chi exercise on bone health and fall prevention in postmenopausal women: a meta-analysis. Journal of Orthopaedic Surgery and Research, 2024. DOI: 10.1186/s13018-024-04962-y PMID: 39127644.
• Lei 2022. The effects of different types of Tai Chi exercises on motor function in patients with Parkinson's disease: A network meta-analysis. Frontiers in Aging Neuroscience, 2022. DOI: 10.3389/fnagi.2022.936027 PMID: 36105909.
• Wayne 2012. Impact of Tai Chi exercise on multiple fracture-related risk factors in post-menopausal osteopenic women: a pilot pragmatic, randomized trial. BMC Complementary and Alternative Medicine, 2012. DOI: 10.1186/1472-6882-12-7 PMID: 22289280.
• Yang 2021. Meta-Analysis of Elderly Lower Body Strength: Different Effects of Tai Chi Exercise on the Knee Joint-Related Muscle Groups. Evidence-based Complementary and Alternative Medicine : eCAM, 2021. DOI: 10.1155/2021/8628182 PMID: 34976101.
• Li 2024a. An RCT META analysis based on the effect of tai chi exercise therapy on the outcome of elderly patients with moderate-to-severe sleep disorders-A systematic review study. Heliyon, 2024. DOI: 10.1016/j.heliyon.2024.e24085 PMID: 38293413.
• Chen 2024. Effects of sedentary behaviour and long-term regular Tai Chi exercise on dynamic stability control during gait initiation in older women. Frontiers in Bioengineering and Biotechnology, 2024. DOI: 10.3389/fbioe.2024.1353270 PMID: 38784770.
• Wang 2023. The influence of Tai Chi exercise on the subjective well-being in the aged: the mediating role of physical fitness and cognitive function. BMC Geriatrics, 2023. DOI: 10.1186/s12877-023-04366-3 PMID: 37814237.
• Chiang 2026. The association of Tai Chi exercise with the methylation levels of the IL20 promoter. Frontiers in Sports and Active Living, 2026. DOI: 10.3389/fspor.2025.1585153 PMID: 41551693.
• Hao 2019. Tai Chi exercise and functional electrical stimulation of lower limb muscles for rehabilitation in older adults with chronic systolic heart failure: a non-randomized clinical trial. Brazilian Journal of Medical and Biological Research, 2019. DOI: 10.1590/1414-431X20198786 PMID: 31778439.
• Kong 2023. Effect of different types of Tai Chi exercise programs on the rate of change in bone mineral density in middle-aged adults at risk of osteoporosis: a randomized controlled trial. Journal of Orthopaedic Surgery and Research, 2023. DOI: 10.1186/s13018-023-04324-0 PMID: 38072989.
• Shen 2010. Green tea polyphenols supplementation and Tai Chi exercise for postmenopausal osteopenic women: safety and quality of life report. BMC Complementary and Alternative Medicine, 2010. DOI: 10.1186/1472-6882-10-76 PMID: 21143878.
• Sani 2023. Tai Chi Exercise for Mental and Physical Well-Being in Patients with Depressive Symptoms: A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health, 2023. DOI: 10.3390/ijerph20042828 PMID: 36833525.
• Kuang 2024. The effects of different types of Tai Chi exercise on anxiety and depression in older adults: a systematic review and network meta-analysis. Frontiers in Public Health, 2024. DOI: 10.3389/fpubh.2023.1295342 PMID: 38259770.
• Yeh 2020. BEAM study (Breathing, Education, Awareness, Movement): a randomised controlled feasibility trial of tai chi exercise in patients with COPD. BMJ Open Respiratory Research, 2020. DOI: 10.1136/bmjresp-2020-000697 PMID: 33219007.
• Dong 2023. Exploring the efficacy of traditional Chinese medicine exercise in alleviating anxiety and depression in older adults: a comprehensive study with randomized controlled trial and network meta-analysis. Frontiers in Psychology, 2023. DOI: 10.3389/fpsyg.2023.1290471 PMID: 38146395.
• Xu 2025. An RCT META analysis based on the efficacy of Tai Chi exercise therapy on blood pressure and blood lipids in patients with essential hypertension. Frontiers in Cardiovascular Medicine, 2025. DOI: 10.3389/fcvm.2025.1506912 PMID: 40873614.
• Liu 2016. Comparative effects of Yi Jin Jing versus Tai Chi exercise training on benign prostatic hyperplasia-related outcomes in older adults: study protocol for a randomized controlled trial. Trials, 2016. DOI: 10.1186/s13063-016-1448-4 PMID: 27422168.
• Wang 2020. Effectiveness of Tai chi exercise on overall quality of life and its physical and psychological components among older adults: a systematic review and meta-analysis. Brazilian Journal of Medical and Biological Research, 2020. DOI: 10.1590/1414-431X202010196 PMID: 32901684.
• Wang 2024. The effects of Tai Chi exercise on sleep quality among the elderly: a study based on polysomnographic monitoring. Frontiers in Neurology, 2024. DOI: 10.3389/fneur.2024.1304463 PMID: 38523606.
• Kalebota 2024. Effects of Tai Chi exercise on pain, functional status, and quality of life in patients with osteoarthritis or inflammatory arthritis. Turkish Journal of Physical Medicine and Rehabilitation, 2024. DOI: 10.5606/tftrd.2024.13140 PMID: 39679119.
• Hao 2026. The relationship between mobile phone dependence, self-control, and Tai Chi exercise among sub-health older adults in urban areas: a latent profile analysis. Frontiers in Public Health, 2026. DOI: 10.3389/fpubh.2026.1759896 PMID: 41756093.
• Chen 2021. Impacts of tai chi exercise on functional fitness in community-dwelling older adults with mild degenerative knee osteoarthritis: a randomized controlled clinical trial. BMC Geriatrics, 2021. DOI: 10.1186/s12877-021-02390-9 PMID: 34332537.
• Li 2024b. Effectiveness of Tai Chi exercise on balance, falls, and motor function in older adults: a meta-analysis. Frontiers in Medicine, 2024. DOI: 10.3389/fmed.2024.1486746 PMID: 39564508.
• Perloff 2021. The Impact of Tai Chi Exercise on Health Care Utilization and Imputed Cost in Residents of Low-Income Senior Housing. Global Advances in Health and Medicine, 2021. DOI: 10.1177/2164956120985479 PMID: 33598365.
• Kang 2022. Functional outcomes of Tai Chi exercise prescription in women with knee osteoarthritis. Sports Medicine and Health Science, 2022. DOI: 10.1016/j.smhs.2022.10.001 PMID: 36600975.
• You 2021. Effects of Tai Chi exercise on improving walking function and posture control in elderly patients with knee osteoarthritis. Medicine, 2021. DOI: 10.1097/MD.0000000000025655 PMID: 33879749.
• Zheng 2021. Effect of Tai Chi exercise on lower limb function and balance ability in patients with knee osteoarthritis. Medicine, 2021. DOI: 10.1097/MD.0000000000027647 PMID: 34797287.
• Hu 2021. Tai Chi exercise can ameliorate physical and mental health of patients with knee osteoarthritis: systematic review and meta-analysis. Clin Rehabil, 2021. DOI: 10.1177/0269215520954343 PMID: 32954819.
• Jiao 2023. Safety and effects of a home-based Tai Chi exercise rehabilitation program in patients with chronic heart failure: study protocol for a randomized controlled trial. Frontiers in Cardiovascular Medicine, 2023. DOI: 10.3389/fcvm.2023.1237539 PMID: 38094121.
• Wu 2018. Effect of Tai Chi Exercise on Balance Function of Stroke Patients: A Meta-Analysis. Medical Science Monitor Basic Research, 2018. DOI: 10.12659/MSMBR.911951 PMID: 30504762.
• Shen 2023. Tai Chi exercise reduces circulating levels of inflammatory oxylipins in postmenopausal women with knee osteoarthritis: results from a pilot study. Frontiers in Medicine, 2023. DOI: 10.3389/fmed.2023.1210170 PMID: 37654656.
• Li 2023. Efficacy and safety of tai chi exercise on bone health: An umbrella review. Osteoporosis International, 2023. DOI: 10.1007/s00198-023-06830-7 PMID: 37430003.
• Zhou 2025. TaiChi-MSS protocol: enhancing cognitive and brain function in MCI patients through Tai Chi exercise combined with multisensory stimulation. Frontiers in Aging Neuroscience, 2025. DOI: 10.3389/fnagi.2025.1514127 PMID: 40071122.
• Jin 2026. Tai Chi exercise and neuroplasticity: a narrative review according to neural mechanisms and clinical utilizations in brain health. Frontiers in Neuroscience, 2026. DOI: 10.3389/fnins.2026.1769779 PMID: 41799887.
• Shi 2022. Quality of Evidence Supporting the Effects of Tai Chi Exercise on Essential Hypertension: An Overview of Systematic Reviews and Meta-Analyses. Cardiology Research and Practice, 2022. DOI: 10.1155/2022/4891729 PMID: 35535247.
• Jain 2022. Effectiveness of Tai Chi Exercise Program on Sleep, Quality of Life, and Physical Performance in Postmenopausal Working Women. Journal of Mid-Life Health, 2022. DOI: 10.4103/jmh.jmh_223_21 PMID: 36276631.
• Hu 2022. Effects of Tai Chi Exercise on Balance Function in Stroke Patients: An Overview of Systematic Review. Neural Plasticity, 2022. DOI: 10.1155/2022/3895514 PMID: 35309256.

Background References

Methodological references cited in prose. Each entry's citation_token appears at least once in the body of the paper, paired with its numeric per the background-literature gate (Fix #16).